Steven Roels

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden

Zachary R. Chalmers, Caitlin Connelly, David Fabrizio et al. · Genome Medicine · 2017 · 3.7K citations · Full text

Medicine, Cancer Biology, Oncology +17

Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors

Garrett M. Frampton, Siraj M. Ali, Mark R. Rosenzweig et al. · Cancer Discovery · 2015 · 796 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib

George Mulligan, Constantine S. Mitsiades, Barbara M. Bryant et al. · Blood · 2006 · 421 citations · Full text

Life Sciences, Molecular Biology, Molecular Medicine +11

The distribution of <i><scp>BRAF</scp></i> gene fusions in solid tumors and response to targeted therapy

Jeffrey S. Ross, Kai Wang, Juliann Chmielecki et al. · International Journal of Cancer · 2015 · 352 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting

Jie He, Omar Abdel‐Wahab, Michelle Nahas et al. · Blood · 2016 · 309 citations · Full text

Medicine, Hematology, Oncology +16